Samsung Biologics Seals PolyPeptide Acquisition
Samsung Biologics is expanding its business territory by investing 2.7 trillion won ($2.08 billion) to acquire PolyPeptide Group, a global contract development and manufacturing organization (CDMO) specializing in peptides. Samsung Biologics announced …